)
IN8bio (INAB) investor relations material
IN8bio Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for May 7, 2026, to be held virtually for shareholders of record as of March 18, 2026.
Shareholders will vote on director elections, auditor ratification, and an equity incentive plan.
Voting matters and shareholder proposals
Election of two Class II directors, Peter Brandt and Corinne Epperly, to serve until the 2029 annual meeting.
Ratification of CohnReznick LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Approval of the Amended and Restated 2026 Equity Incentive Plan.
Board of directors and corporate governance
Two nominees for Class II director positions are presented for election, with terms extending to 2029.
- Annual meeting to vote on director elections, auditor ratification, and expanded equity plan.INAB
Proxy filing26 Mar 2026 - Durable remissions and superior safety achieved with γδ T cell therapies in oncology trials.INAB
Investor presentation23 Mar 2026 - Clinical progress in glioblastoma and improved financials set up key milestones for 2026.INAB
Q4 202513 Mar 2026 - Repeat gamma delta T cell dosing in glioblastoma yields superior survival and safety outcomes.INAB
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - Gamma-delta T cell therapies show durable remissions and major survival gains in glioblastoma.INAB
Noble Capital Markets’ Emerging Growth Virtual Equity Conference5 Feb 2026 - Durable remissions and broad immune targeting drive optimism for upcoming gamma delta T cell data.INAB
H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference3 Feb 2026 - INB-100 prioritized for leukemia after strong early results; other programs paused amid funding challenges.INAB
H.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026 - 14.4M shares registered for resale from a private placement; no proceeds to the company.INAB
Registration Filing20 Jan 2026 - Durable remissions and extended survival achieved with gamma delta T cell therapies in cancer.INAB
Biotech Showcase 202510 Jan 2026
Next IN8bio earnings date
Next IN8bio earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)